BioMarin (BMRN) is up 21.4%, or $11.13 to $63.08.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRN:
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- BioMarin’s Amicus Acquisition: Leveraging Rare-Disease Assets and IP Extension to Drive Blockbuster Growth and Support a Buy Rating
- BioMarin rises 16.7%
- BioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
- BioMarin to Acquire Amicus, Expanding Rare Disease Portfolio